Natera, Inc. (NASDAQ:NTRA – Get Rating) CFO Michael Burkes Brophy sold 1,373 shares of the stock in a transaction dated Wednesday, March 22nd. The stock was sold at an average price of $56.32, for a total transaction of $77,327.36. Following the transaction, the chief financial officer now directly owns 64,833 shares of the company’s stock, […]
Natera, Inc. (NASDAQ:NTRA – Get Rating) CFO Michael Burkes Brophy sold 651 shares of the firm’s stock in a transaction dated Friday, March 24th. The stock was sold at an average price of $55.20, for a total transaction of $35,935.20. Following the sale, the chief financial officer now owns 64,833 shares of the company’s stock, […]
Natera, Inc. (NASDAQ:NTRA – Get Rating) CFO Michael Burkes Brophy sold 651 shares of the company’s stock in a transaction that occurred on Friday, March 24th. The shares were sold at an average price of $55.20, for a total value of $35,935.20. Following the completion of the sale, the chief financial officer now owns 64,833 […]
Natera, Inc. (NASDAQ:NTRA – Get Rating) CFO Michael Burkes Brophy sold 1,373 shares of the business’s stock in a transaction that occurred on Wednesday, March 22nd. The shares were sold at an average price of $56.32, for a total value of $77,327.36. Following the transaction, the chief financial officer now owns 64,833 shares of the […]
Natera (NASDAQ:NTRA – Get Rating) had its price objective upped by Morgan Stanley from $70.00 to $72.00 in a research report released on Thursday, Benzinga reports. They currently have an overweight rating on the medical research company’s stock. Other research analysts also recently issued reports about the company. Piper Sandler boosted their target price on […]